Exact Sciences Q4 EPS Forecast Boosted by Leerink Partnrs
Exact Sciences Co. (NASDAQ:EXAS – Free Report) – Analysts at Leerink Partnrs lifted their Q4 2025 EPS estimates for Exact Sciences in a research report issued on Friday, May 2nd. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will post earnings of $0.26 per share for the quarter, up from their […]
Exact Sciences Co. (NASDAQ:EXAS – Free Report) – Analysts at Leerink Partnrs lifted their Q4 2025 EPS estimates for Exact Sciences in a research report issued on Friday, May 2nd. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will post earnings of $0.26 per share for the quarter, up from their […]
